TearLab Corporation announced the addition of James V. Mazzo to the company's Board of Directors. With his deep industry experience and global reputation, Mr. Mazzo's insights will be invaluable as TearLab seeks to execute its growth strategy on the heels of recent restructuring. One of the ophthalmic industry's most respected business leaders with more than 40 years of proven experience in the medical device space, Mr. Mazzo is internationally renowned for building and running world-class organizations. He has held a number of leadership positions, including CEO of Allergan's North American and European eye care organizations; chairman, president and CEO of Advanced Medical Optics (AMO); EVP of Abbott's global ophthalmology business; executive chair and CEO of AcuFocus; and global president of ophthalmic devices for Carl Zeiss Meditec.